Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02997228
Title Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Atezolizumab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Atezolizumab + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.